Vaishali Pharma reports standalone net loss of Rs 4.29 crore in the March 2025 quarter

Sales decline 0.46% to Rs 32.25 crore

Net Loss of Vaishali Pharma reported to Rs 4.29 crore in the quarter ended March 2025 as against net loss of Rs 4.68 crore during the previous quarter ended March 2024. Sales declined 0.46% to Rs 32.25 crore in the quarter ended March 2025 as against Rs 32.40 crore during the previous quarter ended March 2024.

For the full year,net profit rose 13.89% to Rs 0.82 crore in the year ended March 2025 as against Rs 0.72 crore during the previous year ended March 2024. Sales rose 14.78% to Rs 99.03 crore in the year ended March 2025 as against Rs 86.28 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.Sales32.2532.40 0 99.0386.28 15 OPM %-18.73-20.93 -0.091.33 - PBDT-5.48-6.27 13 1.721.44 19 PBT-5.60-6.41 13 1.230.93 32 NP-4.29-4.68 8 0.820.72 14

Powered by Capital Market - Live News